240 related articles for article (PubMed ID: 18706446)
1. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?
Curnow SJ; Pryce K; Modi N; Knight B; Graham EM; Stewart JE; Fortune F; Stanford MR; Murray PI; Wallace GR
Immunol Lett; 2008 Nov; 121(1):7-12. PubMed ID: 18706446
[TBL] [Abstract][Full Text] [Related]
2. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
Front Immunol; 2021; 12():724900. PubMed ID: 35003055
[TBL] [Abstract][Full Text] [Related]
3. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
[TBL] [Abstract][Full Text] [Related]
4. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease.
Lew W; Chang JY; Jung JY; Bang D
Br J Dermatol; 2008 Mar; 158(3):505-11. PubMed ID: 18205865
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in Behçet's disease.
Sayinalp N; Ozcebe OI; Ozdemir O; Haznedaroğlu IC; Dündar S; Kirazli S
J Rheumatol; 1996 Feb; 23(2):321-2. PubMed ID: 8882039
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.
Yardim-Akaydin S; Sepici A; Ozkan Y; Simşek B; Sepici V
Scand J Rheumatol; 2006; 35(1):61-4. PubMed ID: 16467045
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
10. Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis.
Ozyurt K; Celik A; Sayarlıoglu M; Colgecen E; Incı R; Karakas T; Kelles M; Cetin GY
J Oral Pathol Med; 2014 Oct; 43(9):691-5. PubMed ID: 24801453
[TBL] [Abstract][Full Text] [Related]
11. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
[TBL] [Abstract][Full Text] [Related]
12. Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.
Levinsky RJ; Lehner T
Clin Exp Immunol; 1978 May; 32(2):193-8. PubMed ID: 668196
[TBL] [Abstract][Full Text] [Related]
13. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between leptin G2548A gene polymorphism and Behçet's disease.
Aydin F; Kara N; Senturk N; Gunes S; Canturk MT; Bagci H; Bek Y; Turanli AY
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):68-71. PubMed ID: 17207170
[TBL] [Abstract][Full Text] [Related]
16. Relationship between periodontal findings and specific polymorphisms of interleukin-1alpha and -1beta in Turkish patients with Behçet's disease.
Akman A; Ekinci NC; Kacaroglu H; Yavuzer U; Alpsoy E; Yegin O
Arch Dermatol Res; 2008 Jan; 300(1):19-26. PubMed ID: 17960403
[TBL] [Abstract][Full Text] [Related]
17. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
[TBL] [Abstract][Full Text] [Related]
18. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome.
Akman-Demir G; Tüzün E; Içöz S; Yeşilot N; Yentür SP; Kürtüncü M; Mutlu M; Saruhan-Direskeneli G
Cytokine; 2008 Dec; 44(3):373-6. PubMed ID: 19010690
[TBL] [Abstract][Full Text] [Related]
20. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]